SUMMARY
Reactive oxygen species (ROS) and mitochondrial defects in neurons are implicated in neurodegenerative disease. Here, we find that a key consequence of ROS and neuronal mitochondrial dysfunction is the accumulation of lipid droplets (LD) in glia. In Drosophila, ROS triggers c-Jun-N-terminal Kinase (JNK) and Sterol Regulatory Element Binding Protein (SREBP) activity in neurons leading to LD accumulation in glia prior to or at the onset of neurodegeneration. The accumulated lipids are peroxidated in the presence of ROS. Reducing LD accumulation in glia and lipid peroxidation via targeted lipase overexpression and/or lowering ROS significantly delays the onset of neurodegeneration. Furthermore, a similar pathway leads to glial LD accumulation in Ndufs4 mutant mice with neuronal mitochondrial defects, suggesting that LD accumulation following mitochondrial dysfunction is an evolutionarily conserved phenomenon, and represents an early, transient indicator and promoter of neurodegenerative disease.
INTRODUCTION
Many neurodegenerative diseases are characterized by a gradual demise of neurons, coupled with a reduction in antioxidative capacity and/or an increase in oxidative stress (Turner et al., 2009; Gilgun-Sherki et al., 2001; Lin and Beal, 2006; Keller et al., 2005) . Oxidative stress may result from impaired mitochondrial function and/or glutamate excitotoxicity and causes DNA and protein damage as well as lipid peroxidation (Niki, 2009; Reed, 2011) . These stresses promote damage to neurons and glia and contribute to the demise of neurons (Barnham et al., 2004; Listenberger et al., 2003) . In the cell, complexes I and III of the mitochondrial electron transport chain are the major contributors of free radicals and ROS (Beal, 2007) . Importantly, signs of oxidative stress precede the neurological signs of neurodegeneration (ND) in disease models (Praticò et al., 2001; Keller et al., 2005; Xie et al., 2013) .
Lipid droplets (LDs) are dynamic organelles that emerge from the endoplasmic reticulum (ER) membrane and serve as a site of triglyceride and cholesterol storage. Under normal conditions, LDs are mostly found in liver and adipose tissues and actively respond to cellular signaling (Murphy, 2001; Farese and Walther, 2009) . One important regulator of LD biogenesis is sterol regulatory element binding protein (SREBP), a highly conserved, membrane-bound, basic helix-loop-helix leucine zipper transcription factor that is crucial for lipid homeostasis (Horton et al., 2002) . SREBP regulates lipogenesis and responds to levels of sterols in mammals and palmitate in Drosophila, respectively (Shao and Espenshade, 2012; Dobrosotskaya et al., 2002) . Importantly, Drosophila SREBP mutants are auxotrophs, and SREBP levels are critical in larval stages (Kunte et al., 2006) . Inactive SREBP is a transmembrane protein located in the ER membrane which relocates to the Golgi upon activation where it forms a complex with SREBP-cleavage activating protein (SCAP) (Horton et al., 2002) . In the Golgi, SREBP is cleaved by site-1 and site-2 proteases to generate active SREBP. Active SREBP is then translocated into the nucleus and promotes transcription of genes involved in lipid metabolism (Shao and Espenshade, 2012) . Although SREBP expressed in the gut responds to levels of circulating lipids and cholesterol, the blood-brain-barrier prevents lipids from entering the brain in mammals and de novo lipogenesis is critical for nervous system function (Camargo et al., 2009) . Though the Drosophila nervous system can incorporate lipids from the gut, brain triacylglycerol levels are protected under stress and starvation (Palm et al., 2012; Cheng et al., 2011) .
Cells other than adipocytes can form LDs as a response to cellular inflammation and stress (Santos and Schulze, 2012) . In cancer cells, LDs are hypothesized to be an important source of energy for proliferation and may serve a protective role under conditions of hypoxia and cellular stress by gathering free fatty acids to protect cells against lipotoxicity (Bozza and Viola, 2010) . However, ND has typically not been associated with LD formation in the nervous system, although few mouse mutants have been documented to have LDs in the brain (Mato et al., 1999; Hulshagen et al., 2008; Wang et al., 2002) . Finally, lipid metabolism defects have been implicated in some forms of ALS (Ilieva et al., 2009; Turner et al., 2009; Praticò et al., 2001 ), but not other neurodegenerative diseases.
In this study, we document that ROS induced LD accumulation presages ND in several Drosophila mutants affecting mitochondrial function. We describe a ROS-activated pathway in neurons, which induces LD formation in glia in a cell non-autonomous fashion. Reducing LD accumulation is sufficient to delay ND. Finally, we find that the LD accumulation also occurs in mice with mitochondrial dysfunction, suggesting that LD formation upon oxidative stress is an evolutionarily conserved phenomenon.
RESULTS

Mitochondrial Mutants Exhibit Lipid Droplet Accumulation in Glia
We previously performed forward genetic mosaic screens of essential genes in the Drosophila visual system to uncover genes that cause ND of photoreceptors . While characterizing the phenotypes by transmission electron microscopy (TEM) in the retina and brain, we found structures reminiscent of LDs. In Drosophila, photoreceptors (neurons) project their axons directly into the brain and form synapses with postsynaptic neurons. Pigment cells (glia) ensheath the photoreceptor cell body in the retina and epithelial glia ensheath their axonal terminals (Edwards and Meinertzhagen, 2010) . We found that three different mutants, sicily (Zhang et al., 2013) , Aats-met (Bayat et al., 2012) , and Marf exhibit abundant LD accumulations in pigment ( Figures 1A-1C ) and epithelial glia (Figures S1A-S1C).
These three fly genes play important but distinct roles in mitochondrial biology and mutations in the human homologs cause neurological diseases. sicily is the homolog of the human nuclear encoded mitochondrial gene NDUFAF6 (C8orf38). Its loss leads to an early onset neurodegenerative disease known as Leigh syndrome (Pagliarini et al., 2008) . sicily functions as a chaperone for Complex I proteins and its loss leads to severe mitochondrial dysfunction (Zhang et al., 2013; McKenzie et al., 2011) . Marf encodes the Drosophila homolog of the mitochondrial fusion GTPase, Mitofusin 1 and 2 (Debattisti and Scorrano, 2013) . Mutations in MFN2 cause Charcot-MarieTooth disease type 2A2 (CMT2-A2), an autosomal dominant adult onset peripheral neuropathy (Kijima et al., 2005) as well as Hereditary motor and sensory neuropathy VI (HMSN6) (Del Bo et al., 2008) . Lastly, Aats-met is the Drosophila homolog of mitochondrial methionyl-tRNA synthetase 2, or MARS2. Proteins encoded by these genes mediate the transfer of methionine to their cognate tRNA in the mitochondria matrix. Mutations in MARS2 lead to a disease known as autosomal recessive spastic ataxia with leukoencephalopathy (ARSAL) (Thiffault et al., 2006; Bayat et al., 2012) .
Transmission electron micrographs of 1-day-old wild-type retinal clones show the stereotypical organization of photoreceptors in each ommatidium ( Figure 1A a) . Each ommatidium is separated by thin pigment cells ( Figures 1A a and 1B , pseudocolored in blue). Loss of sicily, Aats-met or Marf leads to an accumulation of LDs (arrow) in glia ( Figures 1A a-d and 1C) , which is not observed in controls. Importantly, LDs are not observed in photoreceptors. In addition to the retina, LDs also accumulate in the epithelial glia of the lamina ( Figure S1A a-d, S1B, and S1C). In summary, LD-like structures are present in cells that function as glia but not in neurons.
To determine whether the structures seen in Figure 1 are indeed LDs, we created large mutant clones in the visual system by GMR-hid (Stowers and Schwarz, 1999) and observed LD accumulation in the glia in sicily, Marf, and Aats-met mutants using Nile Red ( Figure 1D a-d) and BODIPY 493/503 ( Figure S1D ), (Greenspan et al., 1985; Pavlopoulos et al., 1990) . The rhabdomeres (dashed white) are also labeled and serve as reference point for each ommatidium. sicily, Aatsmet and Marf clones show LD accumulation in the area where the glia are located, whereas control animals do not show staining ( Figure 1E ). In summary, mutations in genes involved in three separate mitochondrial processes, Complex I activity, fusion, and protein translation, exhibit LD accumulations in the glia of newly eclosed adults prior to the onset of ND. However, not all mitochondrial mutations cause LD accumulation (see below).
The morphology of sicily, Aats-met, and Marf photoreceptors is mostly normal or only mildly affected at day 1 based on TEM ( Figure 1A ). They begin to degenerate several days after eclosion and the process occurs faster in sicily and Marf mutants than in Aats-met mutant clones ( Figure S1E ) as revealed by fluorescently conjugated phalloidin labeling of actin rich rhabdomeres. Elongated or diffuse rhabdomeres are characteristic for mutants that cause a progressive photoreceptor degeneration (Xiong and Bellen, 2013) .
Lipid Droplets Accumulate Transiently in Glia Next, we sought to characterize the temporal nature of the LD accumulation phenotype. One-day-old sicily, Aats-met and Marf clones exhibit approximately 10 LD per ommatidium. Upon aging, we noticed a significant decrease in the number of LD in the mutant clones (Figures S2A a-i, j-l and S2B), indicating that LD accumulation occurs prior to or concurrent with the onset of ND and is a transient phenomenon ( Figure S2C ).
Increased ROS Correlates with Increased LD Accumulation
Since sicily, Aats-met, and Marf affect mitochondrial function, we sought to investigate the potential link between LD accumulation and mitochondrial dysfunction for other nuclear encoded mitochondrial genes. We knocked down ND42, a CI subunit that is chaperoned by sicily (Zhang et al., 2013) and parkin, an E3 ubiquitin ligase involved in mitochondrial clearance using RNAi. Whole-eye knockdown of both ND42 and parkin leads to LD accumulation ( Figure S3A a and b and Figure 1E ). However, Figure 1E ). In addition, retinal clones of Drp1 2 , which encodes a protein involved in mitochondria fission (Verstreken et al., 2005) , also do not result in LD accumulation ( Figure S3A d and Figure 1E ). The presence of LD accumulations in a subset of mitochondrial mutants suggests that the loss of these genes share a common pathway.
Previously, we noticed elevated levels of reactive oxygen species (ROS) in sicily, Marf, and Aats-met mutants (Zhang et al., 2013; Bayat et al., 2012; Sandoval et al., 2014) . To deter- mine whether increased ROS production and subsequent oxidative stress may promote LD formation, we measured aconitase enzymatic activity in third instar larvae (Yan et al., 1997) . Enzymatic activity for aconitase is less than 50% of wild-type activity in all three mutants as well as ND42 and parkin RNAi knockdown, documenting the presence of high levels of ROS and possibly a threshold effect. Moreover, aconitase activity is less affected (more than 50% of wild-type activity) in Drp1 2 and Pink1 5 mutants ( Figure 1F ). As shown in Figure 1G , there is a strong correlation between decreased aconitase enzymatic activity and the number of LD per ommatidium (R = À0.82). These data suggest that ROS may play a role in LD accumulation.
Reducing ROS Ameliorates Lipid Droplet Accumulation
To establish a causative relationship between ROS and LD accumulation, we employed pharmacologic and genetic methods to reduce ROS and assessed LD. N-acetyl cysteine amide (AD4) is a blood-brain-barrier penetrating antioxidant that can decrease oxidative stress in vitro and in vivo (Schimel et al., 2011; Amer et al., 2008) . We administered AD4 via fly food at concentrations of 20 mg/ml and 40 mg/ml (Bayat et al., 2012) . tion, we overexpressed human copperzinc superoxide dismutase (hSOD1), a conserved antioxidative enzyme that has been shown to rescue or extend Drosophila lifespan (Parkes et al., 1998) . Overexpression of hSOD1 in mutant larvae reduces ROS levels ( Figure 2D ) and considerably suppresses the LD accumulations in glia . To further determine whether the presence of ROS causes LD accumulation, we assessed LD accumulation in SOD mutant flies. SOD n1 mutant (Sun et al., 2012 ) glia also exhibit LD accumulations, similar in levels to what we observe in Aats-met clones (Figures 2E and 2F and 2B) . In summary, these results provide compelling evidence that removing ROS reduces LD accumulation and increasing ROS induces LD accumulation.
Elevated ROS Promotes JNK/ SREBP Activation and Reducing JNK/SREBP Activity Suppresses LD Accumulation Prolonged increase of ROS triggers a stress response that is mediated by cJun-N-terminal Kinase (JNK) signaling in both Drosophila and mammals. JNK activates the transcription of downstream genes, including its own inhibitor, JNK phosphatase. In Drosophila, JNK phosphatase is encoded by puckered (puc), whose expression is used as readout for JNK activity (Martín-Blanco et al., 1998) . ROS can suppress JNK phosphatase activity and therefore allows sustained JNK activation (Kamata et al., 2005) .
Given the presence of LD, we assessed SREBP activity. To determine whether JNK and SREBP are involved in the LD accumulation observed in sicily, Aats-met and Marf clones, we removed a copy of either JNK or SREBP in each mutant background. Removal of a single copy of either JNK or SREBP is sufficient to ameliorate the LD accumulation in all three mutants ( Figures 3A and 3B ). In addition, visual system (ey-GAL4) knockdown of JNK in the sicily and Marf mutant background also significantly reduces LD accumulation ( Figures S4A and S4B) . Furthermore, JNK may be upstream of SREBP as the LD accumulations caused by overexpressing JNK with a neuronal driver in SREBP hemizygous (SREBP 189 /+) flies is strongly suppressed ( Figure S6C and quantified in Figure S6D ) (Kunte et al., 2006) . To determine the extent of JNK upregulation in these mutants, we first performed quantitative RT-PCR in all three mutant larvae and observed an upregulation of puc ( Figure 3C ), suggesting JNK activation. To determine whether JNK is elevated, we used brain lysates from mutant larvae and immunoblotted against total JNK and phosphorylated JNK (pJNK) and found both to be elevated ( Figure S4C ). To further document a persistent elevation of JNK, we performed immunoblots for total JNK in adult heads with mutant eye clones. Although most of the brain is wild-type, much of the visual system is mutant. sicily, Aats-met, and Marf mutants exhibit elevated levels of total JNK ( Figure 3D ), yet only an estimated 40% of the loaded tissue is homozygous mutant. These data indicate that JNK activation correlates with ROS levels.
To test whether SREBP is upregulated in these mutants, we immunoblotted protein extracted from mutant larvae and observed a $five-fold increase in level of active/cleaved SREBP ( Figure S4C ). Mutants that do not exhibit LD accumulation do not exhibit elevated levels (Pink1 5 ) or modest increases of SREBP (Drp1 2 ) ( Figure S4D ). Furthermore, we observe an upregulation of active SREBP as well as an upregulation of Acetyl CoA carboxylase (ACC) in adult heads with mutant clones (Figure 3D ), whose transcription levels are directly regulated by SREBP . JNK is necessary for the activation of SREBP ( Figure 3D ). Moreover, reducing ROS by overexpressing hSOD1 in sicily mutant larvae decreases the levels of JNK and active SREBP ( Figure S4E ). Finally, reducing ROS with AD4 reduces levels of active SREBP in mutant larvae ( Figure S4C ). Our results therefore strongly indicate that ROS stimulates the activation of JNK and SREBP and this axis directly contributes to the LD accumulation phenotype in the nervous system.
Neuronal but Not Glial Mitochondrial Dysfunction Induces Cell Non-Autonomous LD Accumulation in Glia
To determine the cell specific defects that lead to LD accumulation, we knocked down Marf, Aats-met, and ND42 expression with RNAi lines driven by a neuronal driver or pigment glia driver (Bao et al., 2010) . To demonstrate that the glial driver is able to reduce the expression of genes in pigment cells we crossed it to an RNAi against the white gene. As shown in Figure S5 , the 54C-GAL4 driver efficiently reduces pigment levels.
Neuronal expression of RNAi against Marf, Aats-met and ND42 causes significant LD accumulation in glia but not neurons ( Figure 4A a-c and Figure 4B ). However, RNAi in glia for these genes does not result in LD accumulation . Hence, neuronal knockdown of Marf, Aats-met and ND42 is sufficient to lead to LD accumulation glia.
To assess if overexpression of JNK or SREBP is sufficient to induce LD accumulation, we overexpressed JNK, Hemipterous (the Drosophila JNK Kinase), or full-length SREBP using neuronal or glia specific drivers. As shown in Figure 4C , neuronal expression of JNK or SREBP leads to glial cell specific LD accumulation, whereas glial cell specific expression did not. Activation of JNK is required for the LD accumulation phenotype as overexpression of JNKK also leads to LD accumulation. In summary, activation of JNK or SREBP in neurons is sufficient to cause LD in glia.
It is interesting to note that neuronal overexpression of JNK or SREBP alone does not cause ND upon aging ( Figure S5B ) and LDs are retained in aged animals (data not shown). These data show that glial LD accumulation is not sufficient to cause ND, and additional insults are likely to be required.
Neuronal knockdown of Marf, Aats-met, and ND42 leads to LD accumulation in glia. To assess whether a reduction in ROS or JNK in neurons alone is sufficient to reduce LD accumulation in glia, we expressed Marf RNAi under the control of the photoreceptor specific Rhodopsin (Rh1) promoter (Rh-Marf RNAi). Rh-Marf RNAi leads to LD accumulation in glia, but expression of hSOD1 or reduction of JNK (RNAi) using a neuronal driver, significantly reduce LD accumulation. However, when we reduce JNK in glia, LDs are retained ( Figures S7A and S7B) . Hence, elevated ROS and JNK activation in neurons is sufficient and necessary to cause LD accumulation in glia, providing compelling evidence that this neuronal pathway plays a critical role in LD accumulation.
Reduction of LDs Delays Neurodegeneration
To assay ND in various genetic backgrounds, we assessed degeneration as previously mentioned. Upon aging, mutant flies exhibit a significant loss of f-actin staining in rhabdomeres when compared to day 1 ( Figure 5A a-f) . To assay whether reduction of the levels of ROS, JNK, or SREBP suppress LD as well as ND, we analyzed the rhabdomere phenotypes of flies fed with 40 mg/ml of AD4, overexpressing hSOD1, or lacking one copy of JNK or SREBP, by phalloidin staining ( Figure 5A g-r) . These animals contain significantly more intact rhabdomeres when aged compared to mutants alone ( Figure 5B ). These data show that suppression of ROS/JNK/SREBP suppress LD formation and delays ND.
To determine whether reducing LD by ectopic expression of lipases are protective in ND, we expressed two different lipases in mutant clones and assessed ND: Lipase 4 (Lip4), homolog of human acid lipases, functions in starvation mediated lipolysis, and brummer, homolog of adipocyte triglyceride lipase (ATGL), localizes to the LD surface, and acts in lipolysis (Grö nke et al., 2005) . When we expressed the lipases in mutant clones, the expression of either lipase partially restores the shape, density, and number of identifiable rhabdomeres ( Figure 5A s-x, and 5C), indicating that reducing LD accumulation partially alleviates ND. This was confirmed by TEM ( Figure S5C ). 
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Neuronal Glial 6E ) and delays ND. Note that with elav-GAL4 or Rh promoter driven knockdowns of ND42 or Marf, the onset of ND is significantly delayed compared to the ND observed in mutant clones. Finally, reducing lipid load in both cell types seems more potent in delaying ND than reducing lipid load in each cell type separately. Since LD formation alone is not sufficient to induce ND ( Figures 4C and S5B) , and since levels of ROS are elevated in mutants, we explored whether accumulated lipids are peroxidated. Lipids can be peroxidated in presence of ROS and mediate cellular stress (Niki, 2009; Reed, 2011) . To visualize peroxidated lipids, staining with BODIPY 581⁄591 C11 revealed an abundance of peroxidated lipids when compared to controls that do not exhibit LD accumulations ( Figure 6F ). Furthermore, as neuronal overexpression of SREBP leads to LD accumulation but not ND, we assessed lipid peroxidation in animals overexpressing SREBP and observed no difference compared to controls ( Figure 6G ). Finally, neuronal knockdown of ND42 results in LD accumulation and peroxidated lipids. However, this peroxidation is reduced when lipases are expressed neuronally ( Figure 6H ). Hence, these data show that LD accumulation alone is insufficient to cause ND, and ROS is required in conjunction with LD accumulation to promote ND.
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À/À Mice Exhibit Glial LD Accumulation and
Neurodegeneration that Is Significantly Ameliorated with Presymptomatic Antioxidant Treatment
We hypothesized that mitochondrial defects in vertebrates may also lead to LD accumulation in glia, as mitochondrial genes as well as JNK and SREBP are conserved. A mouse model has been generated which permits modeling of Leigh syndrome by removing a mitochondrial Complex I subunit, Ndufs4 (Quintana et al., 2012; Quintana et al., 2010; Kruse et al., 2008) . Mutant Ndufs4 mice develop normally but exhibit signs of encephalomyopathy at postnatal day 30 (P30) and eventually die from breathing defects around P50. These mice develop brain lesions similar to those in Leigh syndrome patients. The KO animals also exhibit reduced activity in Complex I and oxidative stress (Quintana et al., 2012; Assouline et al., 2012) .
To determine whether LD accumulate in Ndufs4 KO mice (Ndufs4 À/À ), we systematically profiled the brain with neutral lipid stains (20 mm coronal sections from the olfactory bulb to the brain stem) of presymptomatic (P23), mid (P35) and late-stage (>P50) mice along with gender and age-matched controls. We observed an abundance of LD in the olfactory bulb (OB) and vestibular nucleus (VN) of P23 brain slices ( Figures 7A a-d and  S7C ). We also observed mild LD accumulation in the periaqueductal gray, cerebellum, dorsal motor nucleus, vagus and abducens nuclei of mutant brains that are not observed in controls (data not shown). As quantified in Figures 7B and 7C , there is an abundance of LDs in the VN of presymptomatic brains but LDs progressively disappear in P34 and P50 mice. We also observed lesions at P34 and >P50 in the areas where LDs accumulated at P23 ( Figures S7A and S7B) . Aside from the VN, LDs also accumulate in the OB of presymptomatic animals. However, unlike in the VN, accumulations in the OB persist throughout the lifespan of the these mice, perhaps of newborn neurons in this region (Ming and Song, 2011) . Interestingly, the areas of the brain with LD accumulation at P23 (VN and the OB) do not exhibit other obvious pathological phenotypes at this time. However, at P34, and especially at P50, the VN and the OB are the main affected regions by lesions and gliosis previously described in Quintana et al. (2012) . These data show that LD accumulation precede physical and histological evidence of ND in mice. In addition, triglyceride (TAG) levels in OB of early-, mid-and late-stage Ndufs4 À/À mice progressively increase ( Figure 7D ). No differences in TAG levels were observed in the brainstem, a small portion of which corresponds to the VN (data not shown).
To determine the cellular specificity of this LD accumulation, we stained for neutral lipids and glial markers. In the OB and VN, LD co-localize with the astrocyte and microglia markers (Figure 7A e-h ). However, LD are rarely seen at P34 and >P50 mice, when there are obvious pathological signs, such as reactive astrocytes and activated microglia. Hence, LDs accumulate in glia prior to the onset of the physical signs of ND in the mutants.
We also assessed JNK activation in the OB of WT and P34 Ndufs4 À/À mice ( Figure 7E) ; a stage at which the highest level of LD is observed in this area ( Figure 7C ). Levels of pJNK are increased in the OB of Ndufs4 À/À mice ( Figure 7E ), suggesting activation of JNK. Finally, neuronal knockdown of fly Ndufs4 (CG12203) via RNAi in neurons also causes LD accumulations in glia, consistent with our observations in mice ( Figures 7F  and 7G ).
As the levels of ROS, JNK and LD are elevated, we tested whether AD4 can delay ND in Ndufs4 À/À mice. KOs were injected intraperitoneally with 150 mg/kg/day from P21 to P28. This short treatment leads to a delay in onset and reduction in severity of clinical signs throughout the lifespan of treated mice ( Figure 7H ). By P30, the treated KO mice have a significantly delayed latency to fall in the rotarod assay compared to saline treated KO mice ( Figure 7I ). Thus, a brief administration of AD4 is sufficient to delay the onset of ND and motor defects in Ndufs4 À/À mice, arguing that increased ROS plays a role in the pathogenesis.
DISCUSSION
Here, we show that neuronal mitochondrial defects that lead to elevated levels of ROS, induce activation of JNK and SREBP, which in turn elevate lipid synthesis in neurons and formation of LD in glial cells. These LDs contribute to and promote ND through elevated levels of lipid peroxidation. LDs form in glia prior to or at the onset of the appearance of obvious degenerative histological features in Drosophila and mice. Reducing the number and size of LD pharmacologically or genetically delays ND in the fly. To our knowledge, this is the first indication that SREBP, lipid droplet biogenesis, and lipid metabolism play a role in the pathogenesis of several neurodegenerative diseases. A growing body of evidence points to the importance of glial health and function in nervous system energy metabolism and homeostasis (Bé langer et al., 2011) . Nevertheless, given the number and prevalence of different types of neurodegenerative diseases, very few reports have documented the presence of LDs in either neuron or glia in patients and in animal models. LD accumulation in the brain has been reported in cells that line the ventricles in the globus pallidus and substantia nigra in mutant mice lacking both subunits of the liver X receptor (Wang et al., 2002) , apolipoprotein E (Mato et al., 1999) , or a peroxisomal biogenesis factor (Pex5) (Hulshagen et al., 2008) . In addition, in vitro studies using immortalized cell lines and explants show that LD may form and accumulate in glia under conditions of nutrient deprivation or lipopolysaccharide induced stress (Cabodevilla et al., 2013; Bozza and Viola, 2010) . However, LDs have not been shown to play an active role in neurodegenerative processes. Furthermore, LD accumulation has not been reported in patients with or animal models of Leigh syndrome (NDUFS4/Ndufs4, NDUFAF6/sicily), CMT-2A2 or HMSN6 (MFN2/Marf), and ARSAL (MARS2/Aats-met) (Assouline et al., 2012; McKenzie et al., 2011; Pagliarini et al., 2008; Boaretto et al., 2010; Bayat et al., 2012; Thiffault et al., 2006) . The lack of neuropathological reports of LDs in animal models or in patients with ND may be attributed to the fact that LD accumulation is transient and mostly occur during presymptomatic stages of the disease.
Although these genes/mutants are implicated in very different mitochondrial processes, they exhibit a common phenotype of elevated levels of ROS, leading to LD accumulation. Similar morphological changes of glia have been reported under stress conditions (Boche et al., 2013; Pekny and Nilsson, 2005 (legend continued on next page) 2012), without compelling results. The LD accumulation phenotype in our mutants occurs prior to histopathological and physical signs of ND. A brief period of AD4 delivery prior to the onset of symptoms in mutant mice is effective in delaying onset of clinical signs. Thus, therapy with an effective antioxidant that penetrates the blood-brain barrier should be started early and sustained over long periods. In addition, pharmacological manipulation of JNK or lipid levels in the brain may serve as a potential therapy to delay the onset of ND. However, similar to antioxidant treatment, this may need to be administered at an early stage. Hence, early identification of potential ROS related neurological disease based on genetic/genomic diagnosis or by biomarkers may be critical. Since LD accumulation is one of the earliest presymptomatic changes that occurs in the nervous system, detection of LD itself or changes in neurometabolism may be a promising biomarker. In summary, we provide evidence for the role of altered lipid metabolism and a neuron-glia interplay that promotes ND. In some mitochondrial mutants, we observe an upregulation of SREBP as well as lipid biogenesis and glial LD formation. The accumulation of LD is not sufficient to promote the ND process itself. However, in the presence of ROS the accumulated lipids are peroxidated and promote ND, possibly by promoting the release of lipids from LD, elevating the cytoplasmic load, and causing a progressive loss of LD. Hence, the synergistic effects of increased lipid synthesis and/or LD accumulation in combination with elevated ROS and lipid peroxidation promote ND. Finally, we show that LD accumulation occurs at the onset or precedes ND in flies and mice, suggesting that LD and changes in lipid metabolism in the nervous system may be a promising biomarker to identify brain regions susceptible to but not yet exhibiting symptoms of ND.
EXPERIMENTAL PROCEDURES Lipid Droplet Staining
For whole-mount staining of fly retinas, heads were dissected in cold PBS and fixed in 3.7% formaldehyde for 1 hr. Subsequently, the retinas were dissected and fixed for an additional 30 min. Retinas were rinsed several times with 13 PBS and incubated for 10 min at 1:1,000 dilution of PBS with 1 mg/ml Nile Red (Sigma) or BODIPY 493/503 (Life Technologies). Subsequently, tissues were rinsed with PBS and immediately mounted with Vectashield (Vector Labs) for same-day imaging. Images were obtained with a Zeiss LSM 510 microscope. For LD staining in the CNS, mice were perfused transcardially with 4% paraformaldehyde. Brains were extracted and post-fixed in the same fixative overnight at 4 C and then dehydrated in sucrose. They were then embedded in OCT (Tissue-Tek) and cryosectioned at 20 mm per slice. Slides were submerged in 13 PBS for 10 min and then incubated for 10 min in Nile Red/ BODIPY as above. Subsequently, the slides were washed twice with 13 PBS and immediately covered with Vectashield mounting medium with DAPI (Vector Labs) for same-day imaging.
Lipid Peroxidation
Procedures with C11-BODIPY 581/591 were adapted for tissue staining instead of cell culture as described in (Drummen et al., 2002) . BODIPY was solubilized in 50 ml DMSO and was added to a final concentration of 20 mM in BSA. For live tissue staining of mutant retinas, whole flies were pinned to Sylgard silicone elastomer plates and submerged with 1% BSA and BODIPY. Tungsten needles were used to slice the cuticle around the eye for optimal dye penetration.
Plates were incubated for 30 min at 37 C and subsequently rinsed with 13 PBS before the retinas were sliced out, mounted with Vectashield, and imaged immediately.
Tissue Triglyceride Quantification
Triglyceride levels in OB samples (n = 6 for WT mice, n = 3 for each Ndufs4 mice group) were determined using the PicoProbe Triglyceride Quantification Assay Kit (Abcam) according to manufacturer's directions. Wild-type mice included age-matched controls.
AD4 Administration
Control and KO mice were administered i.p. daily for 7 days with either saline (CT SAL, n = 11; KO SAL, n = 7) or 150 mg/kg AD4 (KO AD4, n = 6) from day P21 unil P28. Assouline, Z., Jambou, M., Rio, M., Bole-Feysot, C., de Lonlay, P., Barnerias, C., Desguerre, I., Bonnemains, C., Guillermet, C., Steffann, J., et al. (2012) . A constant and similar assembly defect of mitochondrial respiratory chain complex I allows rapid identification of NDUFS4 mutations in patients with Leigh syndrome. Biochim. Biophys. Acta 1822, 1062-1069. See also Figure S7 .
SUPPLEMENTAL INFORMATION
